A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

计划入组 154 人 · 首次发布于 2025 年 5 月 13 日

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

计划入组 55 人 · 首次发布于 2024 年 5 月 2 日

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

计划入组 63 人 · 首次发布于 2019 年 2 月 7 日

S-2512

MK-2512

Debio-0617B

Debiopharm Advances Bispecific ADC Development with SunRock Biopharma's Anti-HER2/HER3 Antibody License

Debiopharm Initiates Phase III Trial for Quarterly Acromegaly Treatment Debio 4126

Debiopharm Initiates First-in-Human Trial of CD37-Targeted ADC Debio 1562M for Relapsed/Refractory AML